Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The endogenous extracellular matrix (ECM) is a complex, non-cellular three-dimensional macromolecular network composed of collagens, proteoglycans, glycosaminoglycans, and glycoproteins that provide essential structural and biochemical support to tissues (Frantz et al., 2010, J Cell Sci). Beyond its role as a physical scaffold, the ECM acts as a dynamic signaling hub, regulating cell behavior such as proliferation, migration, and differentiation through interactions with cell-surface receptors like integrins (Hynes, 2009, Science). In various diseases, the ECM undergoes pathological remodeling; for instance, excessive deposition of collagen leads to organ fibrosis, while the degradation of matrix components by enzymes like matrix metalloproteinases (MMPs) facilitates tumor invasion and metastasis (Lu et al., 2012, J Cell Biol). Pharmacological targeting of the ECM is a diverse field, ranging from the use of enzymatic agents like collagenase clostridium histolyticum to treat Dupuytren's contracture to the application of hyaluronidase to increase tissue permeability for drug delivery (Hurst et al., 2009, N Engl J Med; Bookbinder et al., 2006, J Control Release). Additionally, exogenous ECM molecules like hyaluronic acid and chondroitin sulfate are utilized as viscosupplements in the management of osteoarthritis (Bannuru et al., 2019, Ann Intern Med). While the ECM presents a rich landscape for therapeutic intervention, its ubiquitous presence in the body necessitates high specificity to avoid adverse effects on normal tissue architecture and the body's natural repair mechanisms.
Therapeutic strategies involve the enzymatic degradation of accumulated matrix components (e.g., collagen or hyaluronan), the inhibition of cross-linking enzymes such as lysyl oxidase-like 2 (LOXL2) to prevent matrix stiffening, or the use of exogenous ECM components to restore tissue lubrication and integrity.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endogenous extracellular matrix molecules (ECM).